58.4K
Downloads
272
Episodes
The Video Journal of Hematology and Hematological Oncology (VJHemOnc) podcast covers the latest hematological oncology and hematology news from international experts – from leukemias, lymphomas, MDS and MPNs, to sickle cell, aplastic anemia and rare diseases. Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion. If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjhemonc.com
Episodes
Tuesday Mar 16, 2021
Tuesday Mar 16, 2021
The armamentarium of therapeutic modalities in acute myeloid leukemia (AML) has taken several strides in the last few years as a result of a greater understanding of the genomic landscape disease as well as how resistance to conventional therapies can develop.
At the virtual 62nd American Society of Hematology 2020 Annual Meeting and Exposition (ASH 2020), we spoke with key opinion leaders in AML who shared the novel classes of drugs currently investigated in this disease area, which provide the field new opportunities for effective combination strategies.
In this podcast, Marina Konopleva, of the University of Texas MD Anderson Cancer Center, Houston, TX, David Sallman, of Moffitt Cancer Center, Tampa, FL, and Naval Daver, of the University of Texas MD Anderson Cancer Center, discuss some of the latest updates in AML presented at this year’s virtual American Society of Hematology (ASH) meeting.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.